Trial intelligence / Profile preview

Early intravenous metoprolol before reperfusion in STEMI planned for primary PCI

2010-023394-19Phase 3Completed

Sponsor
Maatschap Cardiologie Isala
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of metoprolol in acute ST-segment elevation myocardial infarction (STEMI) and anterior myocardial infarction (AWMI) (2 arms), sponsored by Maatschap Cardiologie Isala. Primary endpoint: Infarct size. Started Nov 2010; status: completed.

02

Drugs

metoprolol
03

Conditions

acute ST-segment elevation myocardial infarction (STEMI)anterior myocardial infarction (AWMI)

Beyond the preview

Go deeper on 2010-023394-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023394-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call